Skip to content
Bamboo Works
Search
Register / Sign in
MSCI China
|
MSCI China Small-Cap
|
Hang Seng Index
|
Hang Seng China Enterprise
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
    • China ESG Focus
  • Fast News
  • Expert Corner
  • Audio/Video
  • IPO
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • Eng
  • 简中
  • 繁中
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
    • China ESG Focus
  • Fast News
  • Expert Corner
  • Audio/Video
  • IPO
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

Neautus

Neautus made an IPO

Traditional medicine maker Neautus rises 72% in Hong Kong trading debut

Shares of Sichuan Neautus Traditional Chinese Medicine Co. Ltd. (2206.HK) jumped in their Hong Kong trading debut on Wednesday, as retail investors clamored to buy into China’s largest private producer…
November 11, 2026
Neautus made an IPO

Neautus launches Hong Kong IPO at up to HK$3.3 billion valuation

Sichuan Neautus Traditional Chinese Medicine Co. Ltd. (2206.HK) launched its Hong Kong IPO on Oct. 30, targeting a valuation of up to HK$3.3 billion ($423 million), as it seeks to…
November 2, 2026
Neautus turns away from mainland listing to Hong Kong IPO to fund business expansion

Neautus looks outward to boost its traditional medicine story

The maker of traditional Chinese medicines has applied for a Hong Kong IPO after abandoning two listing attempts on China’s domestic A-share market Key Takeaways: Neautus has applied to list…
April 15, 2025

Recent Articles

Neautus made an IPO
November 11, 2026

Traditional medicine maker Neautus rises 72% in Hong Kong trading debut

November 2, 2026

Neautus launches Hong Kong IPO at up to HK$3.3 billion valuation

April 15, 2025

Neautus looks outward to boost its traditional medicine story

RELATED ARTICLES

  1. Intensifying population aging spurs northern traditional Chinese medicine leader Yuyantang to seek Hong Kong listing
    August 5, 2026
    Traditional Chinese medicine leader Yuyantang finds tonic in aging population
  2. November 2, 2026
    Neautus launches Hong Kong IPO at up to HK$3.3 billion valuation
  3. July 7, 2026
    Tong Ren Tang Healthcare makes trading debut, backed by 39% annual patient growth
  4. June 30, 2026
    JBM Healthcare gets bitter pill from investors on anemic performance
    2161.HK
  5. July 10, 2026
    Gushengtang steps up TCM buying spree, doubling down in Beijing
    2273.HK
  6. September 29, 2026
    Kinwong Electronic rises in Hong Kong trading debut, reversing opening decline
    3228.HK
    603228.SHG
  7. July 8, 2026
    Eacon Group rises in Hong Kong trading debut
    7687.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

China stock insights and analysis for global investors: Bamboo Works unlocks investment opportunities in Chinese companies listed in the U.S. & Hong Kong.

  • About Us
  • Fast News
  • Audio/Video
  • Expert Corner
  • China ESG
Facebook Twitter Linkedin Weixin Weibo Youtube

Categories

  • New Energy
  • IPO
  • AI/Infrastructure/Resources
  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • Property

Newsletter

Discover hidden China stock gems in our weekly newsletter
Copyright © 2021 - 2026 Bamboo Works. All rights reserved.